Update on recent developments for patients with newly diagnosed multiple myeloma

Annals of the New York Academy of Sciences

Volumn 1138, Issue , 2008, Pages 19-21

  Palumbo, Antonio ^a   Magarotto, Valeria ^a   Gay, Francesca ^a   Falco, Patrizia ^a   Bringhen, Sara ^a   Boccadoro, Mario ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bortezomib; Lenalidomide; Multiple myeloma; Thalidomide

Indexed keywords

ACETYLSALICYLIC ACID; BORTEZOMIB; DEXAMETHASONE; LENALIDOMIDE; MELPHALAN; PREDNISONE; THALIDOMIDE;

ADD ON THERAPY; ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; DEEP VEIN THROMBOSIS; DIARRHEA; DOSE CALCULATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GERIATRIC CARE; HUMAN; INFECTION; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NAUSEA; NEUROPATHY; NEUTROPENIA; RISK REDUCTION; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 53149143582     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1414.004     Document Type: Conference Paper

References (8)

1. Richardson, P.G. 2005. Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed myeloma. J. Clin. Oncol. 23 : 568s (Abstract 6533).
2. Jagannath, S. 2005. Bortezomib therapy alone and in combination with dexamethasone for patients with previously untreated multiple myeloma. Blood 106 (Abstract 783).
3. Mateos, M. 2005. A phase I/II national, multi-center, open-label study of bortezomib plus melphalan and prednisone (V-MP) in elderly untreated multiple myeloma (MM) patients. Blood 106 (Abstract 786).
4. Hernandez, J.M. 2004. Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma. Br. J. Haematol. 127 : 159 164.
5. Facon, T. 2005. Major superiority of melphalan - prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. Blood 106 (Abstract 780).
6. Palumbo, A. 2005. Oral melphalan, prednisone and thalidomide for multiple myeloma. Blood 106 (Abstract 779).
7. Palumbo, A. 2006. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet 367 : 825 831.
8. Palumbo, A. 2005. Oral Revlimid® Plus melphalan and prednisone (R-MP) for newly diagnosed multiple myeloma. Blood 106 (Abstract 785).